- Home
- BRLT vs AIDX Comparison
BRLT vs AIDX Comparison
Compare BRLT & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRLT | AIDX |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.0M | 19.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRLT | AIDX |
|---|---|---|
| Price | $1.32 | $2.05 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $1.70 | N/A |
| AVG Volume (30 Days) | 45.8K | ★ 158.6K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $437,483,000.00 | N/A |
| Revenue This Year | $6.72 | N/A |
| Revenue Next Year | $4.95 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.63 | N/A |
| 52 Week Low | $1.21 | $1.51 |
| 52 Week High | $3.10 | $14.09 |
Technical Indicators
Market Signals| Indicator | BRLT | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.81 | 17.56 |
| Support Level | $1.25 | $1.51 |
| Resistance Level | $1.66 | N/A |
| Average True Range (ATR) | 0.09 | 0.22 |
| MACD | 0.01 | 0.29 |
| Stochastic Oscillator | 58.82 | 78.25 |
Price Performance
Historical ComparisonAbout BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is an digitally native omnichannel jewelry company selling The company's products include rings, necklaces, earrings, and bracelets. Its collection of premium-quality diamond engagement and wedding rings, gemstone rings, and fine jewelry is conceptualized by in-house design studio. The company operates in one operating and reporting segment, the retail sale of diamonds, gemstones and jewelry.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.